Clinical Trials Browser

Unknown × Carcinoma, Non-Small-Cell Lung × Dasatinib × Clear all

NCT04284202 2020-02-25

PD-1 Combined With Dasatinib for as Third-line Treatment for ARID1A Mutation Advanced NSCLC

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung